| Literature DB >> 35885322 |
Natale Cristine C Carvalho1, Odair S Monteiro2, Claudia Q da Rocha2, Giovanna B Longato3, Robert E Smith4, Joyce Kelly R da Silva1, José Guilherme S Maia1,2.
Abstract
Annona crassiflora Mart., the marolo fruit of the Cerrado biome, is one of the most frequently consumed species from the Brazilian Midwest. This study aimed to evaluate the chemical composition and the antioxidant and cytotoxic properties of the fruit pulp of A. crassiflora collected at Chapada das Mesas, Maranhão, Brazil. The volatile concentrate was identified as mainly ethyl octanoate, ethyl hexanoate, and methyl octanoate. From the ethanol (LFP-E) and ethyl acetate (LFP-A) extracts were identified phenolic acids (p-coumaric, gallic, quinic, and ferulic), flavones and derivatives (apigenin, epicatechin, 2'-5-dimethoxyflavone, 3',7-dimethoxy-3-hydroxyflavone, kaempferol-3-O-glucoside and 3-O-rutinoside, quercetin-3-O-glucoside, procyanidin B2, and rutin), aporphine alkaloids (xylopine, stephagine, and romucosine), and acetogenin (annonacin). For the LFP-E and LFP-A extracts, the total phenolic compound values were 15.89 and 33.16 mg GAE/g, the flavonoid compound content values were 2.53 and 70.55 mg QE/g, the DPPH radical scavenging activity showed EC50 values of 182.54 and 57.80 µg/mL, and the ABTS radical activity showed TEAC values of 94.66 and 192.61 µM TE/g. The LFP-E extract showed significant cytotoxicity and cell selectivity for the U251-glioma strain, presenting a GI50 value of 21.34 µg/mL, which is close to doxorubicin (11.68 µg/mL), the standard chemotherapeutic drug. The marolo fruit seems to be a promising source for developing innovative and healthy products for the food industry.Entities:
Keywords: antioxidant and antiproliferative activities; marolo fruit; phenolic compounds; volatile concentrate
Year: 2022 PMID: 35885322 PMCID: PMC9320407 DOI: 10.3390/foods11142079
Source DB: PubMed Journal: Foods ISSN: 2304-8158
Mass spectral characteristics of secondary compounds detected by HPLC-ESI-IT-MS in the A. crassiflora pulp fruit extracts at negative ionization mode *.
| LFP-E and | Compounds | RT (min) | [M-H]- | MSn Fragments ( |
|---|---|---|---|---|
| 1 | 2.1 | 163 | 119(45), 93(100) | |
| 2 | Gallic acid a | 2.1 | 169 | 125(25) |
| 3 | Quinic acid a,b | 2.3 | 191 | 173(40), 85(100) |
| 4 | Ferulic acid b | 2.4 | 193 | 178(35), 149(100), 134(25) |
| 5 | Apigenin b | 7.2 | 269 | 151(100), 117(35) |
| 6 | Rutin a | 12.3 | 609 | 463(25), 301(100) |
| 7 | Kaempferol 3-O-β-D-glucoside a,b | 12.9 | 447 | 285(100), 152(25) |
| 8 | Kaempferol-3-O-rutinoside a | 13.1 | 593 | 285(100), 255(45) |
| 9 | Quercetin-3-O-β-D-glucoside a | 14.2 | 463 | 301(100) |
| 10 | Procyanidin B2 a | 16.1 | 577 | 541(35), 425(35), 407(25), 289(100) |
| 11 | (-)-Epicatechin a | 18.3 | 289 | 271(100), 163(50) |
| 12 | Xylopine a,b | 18.6 | 294 | 264(100), 249(35), 219(45), 191(25) |
| 13 | 3′,7-Dimethoxy-3-hydroxyflavone a,b | 19.6 | 297 | 265(100), 249(15), 183(18) |
| 14 | 2′,5-Dimethoxyflavone a | 19.7 | 281 | 151(100) |
| 15 | Stephalagine a | 19.7 | 308 | 278(100) |
| 16 | Romucosine a | 19.9 | 322 | 267(100), 252(35) |
| 17 | Annonacin a | 21.2 | 595 | 471(100), 379(35), 361(28), 343(25) |
* Identification by comparison of retention times and mass spectra data with reference compounds; a Identified in LFP-E extract, (hydroethanolic); b Identified in LFP-A extract (ethyl acetate); c Relative ionic abundance for each ion is in parentheses.
Figure 1Constituents identified in the hydroethanolic and ethyl acetate extracts from fruit pulp of A. crassiflora (see Table 1).
Constituents of volatile concentrate of lyophilized fruit pulp of Annona crassiflora.
| Constituents | RIC | RIL | Concentrate | Constituents | RIC | RIL | Concentrate (%) |
|---|---|---|---|---|---|---|---|
| 799 | 800 a | 0.1 |
| 1195 | 1196 a |
| |
| 861 | 863 a | 0.2 | Ethyl ( | 1245 | 1245 a | 0.3 | |
| 2-Heptanone | 888 | 889 a | 0.1 | Isopentyl hexanoate | 1249 | 1252 b | 0.8 |
| Methyl hexanoate | 920 | 921 a | 2.4 | ( | 1260 | 1260 a | 2.0 |
| Hexanoic acid | 965 | 967 a | 0.1 | ( | 1290 | 1292 a | 0.5 |
|
| 996 | 997 a |
| Methyl decanoate | 1321 | 1323 a | 0.1 |
| 1061 | 1063 a | 0.1 | Hexenyl ( | 1381 | 1382 b | 0.2 | |
| Propyl hexanoate | 1094 | 1096 b | 0.1 | Hexyl hexanoate | 1386 | 1390 b | 0.1 |
| 1100 | 1100 a | 0.1 | Ethyl decanoate | 1395 | 1395 a | 0.7 | |
|
| 1122 | 1123 a |
| Ethyl dodecanoate | 1596 | 1598 b | 0.5 |
| Isobutyl hexanoate | 1149 | 1149 a | 0.1 | Ethyl tetradecanoate | 1794 | 1795 a | 1.8 |
| Octanoic acid | 1164 | 1167 a | 1.1 | Ethyl hexadecanoate | 1991 | 1992 a | 0.1 |
| Butyl hexanoate | 1185 | 1186 a | 0.2 | ||||
| Total (%) | 94.2 | ||||||
RIC = Calculated Retention Index (Rxi-5ms column); RIL = Literature Retention Index; Bold = Main constituents; a Adams 2007 [26]; b Mondello 2011 [27].
Figure 2Antioxidant capacity of A. crassiflora extracts: (A) EC50 values of DPPH radical scavenging, (B) Total antioxidant capacity based on ABTS method. a,b Different letters represent statistical difference by Tukey test (p < 0.05).
Antiproliferative activity of A. crassiflora hydroethanolic extract against human tumor cell lines.
| Extract/Standard | Cell Lines (GI50 µg/mL) | ||||||
|---|---|---|---|---|---|---|---|
| U251 | MCF-7 | PC-3 | OVCAR-3 | HT29 | HaCaT | HEPG2 | |
| LFP-E | 21.34 | >100 | >100 | >100 | >100 | >100 | >100 |
| Doxorubicin | 11.68 | 3.09 | 24.46 | 53.92 | 26.16 | 4.79 | 27.53 |
Figure 3Growth inhibition of the tumor cell lines after LFP-E extract treatment (48 h).